Valeant Pharmaceuticals International Inc. Chief Executive Officer Michael Pearson is taking a medical leave of absence, putting management of the embattled drugmaker in the hands of a team of executives.
In a statement Monday, the company gave no update on the condition of Pearson, who was hospitalized last week with a severe case of pneumonia. The shares sank 8.7 percent to $104.14 at 10:16 a.m. in New York.
Also read: Carlos Ghosn Resigns as Nissan CEO
11:33 Gaizka Garitano sacked as Deportivo La Coruna coach after winless run15
05:05 Lonzo Ball's dad says son will 'only play for the Lakers'22
18:13 Warren Buffett's Shareholder Letter: 5 Lessons for All Investors21
03:02 SK Hynix CEO says will consider fresh bid for Toshiba chip unit stake20